您的位置: 首页 > 农业专利 > 详情页

NOVEL ANTI-DR5 ANTIBODY
专利权人:
Daiichi Sankyo Company Limited
发明人:
OHTSUKA, Toshiaki,TAKIZAWA, Takeshi,OGUNI, Akiko,MATSUOKA, Tatsuji,YOSHIDA, Hiroko,MATSUI, Yumi
申请号:
HK14102421.9
公开号:
HK1189622B
申请日:
2014.03.11
申请国别(地区):
HK
年份:
2016
代理人:
摘要:
The present invention relates to an antibody which has a therapeutic effect on cancer, an autoimmune disease, or an inflammatory disease. That is, the present invention relates to an antibody which exhibits a cytotoxic activity against death domain-containing receptor-expressing cells through apoptosis. [Object] An object of the invention is to provide a pharmaceutical having a therapeutic effect on cancer. [Means for Resolution] A novel anti-DR5 antibody capable of inducing apoptosis in cells has more potent cytotoxic activity than currently available anti-DR5 antibodies.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充